A study of Quadrivalent influenza vaccine

Trial Profile

A study of Quadrivalent influenza vaccine

Phase of Trial: Phase I

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs Influenza-virus-vaccine-quadrivalent-Sinovac-Biotech (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 28 Nov 2017 New trial record
    • 22 Nov 2017 According to a Sinovac Biotech media release, the CFDA approved this trial in November 2016 and the trial is expected to be initiated in the fourth quarter of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top